News in the Life Sciences Industry

LIVERPOOL, England, July 7, 2020 /PRNewswire/ -- The University of Liverpool, Liverpool School of Tropical Medicine, and Southampton Clinical Trials Unit announced this week that they have launched their innovative COVID-19 drug testing platform, AGILE. The AGILE initiative is a collaboration... Read more ››

LONDON, July 6, 2020 /PRNewswire/ -- Thousands of pharmacies are to be offered material financial assistance thanks to a groundbreaking advanced payment system developed by Greensill, Britain's leading fintech provider of working capital finance, and NHS Business Service Authority (NHSBSA).

LONDON, July 6, 2020 /PRNewswire/ -- IVIRMA, a global network of fertility clinics and world-leading pioneer in fertility research, are presenting a breakthrough study at the 36(th) Congress of the European Society of Human Reproduction and Embryology (ESHRE) today, demonstrating the possibility... Read more ››

LONDON, July 6, 2020 /PRNewswire/ -- Sustainability is about more than just responsible environmental policy. A functioning society is also hugely dependent on the health of its population, yet 41 million people are still dying annually from preventable non-communicable diseases (NCDs) such as... Read more ››

LAVAL, QC and CAMBRIDGE, England, July 2, 2020 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, today announced that Prometic Plasma Resources, a subsidiary of Liminal BioSciences Inc., has... Read more ››

OSLO, Norway, July 1, 2020 /PRNewswire/ -- Nordic Nanovector ASA - share capital increase registered

Enhanced Newport platform allows for comprehensive and accurate analysis of market, API and patent data from a single application

SEOUL, Korea, June 30, 2020 /PRNewswire/ -- Janssen Korea Ltd. and Johnson & Johnson Innovation LLC today announced the launch of the Seoul Innovation QuickFire Challenge for Healthcare in the New Normal in collaboration with the Seoul Metropolitan Government (SMG) and the... Read more ››

- QuickFire Challenge calls on innovators to identify and accelerate potential solutions aiming to improve patient care in our post-COVID world.

LAVAL, QC and CAMBRIDGE, England, June 30, 2020 /CNW Telbec/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, today provided a guidance update on the timing of certain expected key milestones for 2020.